Healthcare >> Analyst Interviews >> November 12, 2007

OUTLOOK FOR SPECIALTY PHARMACEUTICALS – DAVID LICKRISH – BROADPOINT CAPITAL, INC.

TWST: Where do you focus your attention in specialty pharma?

Mr. Lickrish: For our purposes at Broadpoint Capital, we define specialty pharma

as those companies that don't engage in primary